Showing results (1191-1200 of 1,984) with videos related to
Sort By:
Pageof 199
The Lancet. Neurology|May 18, 2019
Small vessel disease: mechanisms and clinical implicationsJoanna M Wardlaw, Colin Smith, Martin DichgansThe Lancet. Neurology|April 21, 2019
Therapeutic interventions in patients with prolonged disorders of consciousnessAurore Thibaut, Nicholas Schiff, Joseph Giacino, et al.The Lancet. Neurology|May 12, 2019
Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathyCarina Bunschoten, Bart C Jacobs, Peter Y K Van den Bergh, et al.The Lancet. Neurology|September 15, 2019
New evidence on the management of Lewy body dementiaJohn-Paul Taylor, Ian G McKeith, David J Burn, et al.The Lancet. Neurology|September 9, 2019
Dementia in China: epidemiology, clinical management, and research advancesLongfei Jia, Meina Quan, Yue Fu, et al.The Lancet. Neurology|May 17, 2011
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS studyBhupendra Khatri, Frederik Barkhof, Giancarlo Comi, et al.The Lancet. Neurology|March 15, 2011
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysisGavin Giovannoni, Stuart Cook, Kottil Rammohan, et al.The Lancet. Neurology|May 24, 2011
Primary angiitis of the CNSRula A Hajj-Ali, Aneesh B Singhal, Susanne Benseler, et al.The Lancet. Neurology|February 15, 2011
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trialRobert A Hauser, Marc Cantillon, Emmanuelle Pourcher, et al.The Lancet. Neurology|February 26, 2011
Apolipoprotein E in Alzheimer's disease and other neurological disordersPhilip B Verghese, Joseph M Castellano, David M HoltzmanPageof 199